The clinical data of colorectal cancer patients from the KM-plotter database further verified that patients with high SLC35A3 expression had significantly better OS, RFS, and PPS than those with low SLC35A3 expression (Fig. 3F–K). This evidence concerns the gene SLC35A3 and colorectal cancer.